orthospinenews

About orthospinenews

This author has not yet filled in any details.
So far orthospinenews has created 464 blog entries.

Medicrea Reports First Half 2018 Results

September 19, 2018 LYON, France & NEW YORK--(BUSINESS WIRE)--The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) technology, has today published its unaudited results for the

By |2018-09-19T15:35:27+00:00September 19th, 2018|Financial|

SpineGuard Reports Six-Month 2018 Financial Results

September 18, 2018 PARIS & SAN FRANCISCO--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that designs, develops, and markets disposable medical devices intended to make spine surgery safer by bringing real-time digital technology into the operating room, announced today financial results for the half year ending June 30, 2018, as approved by

By |2018-09-19T15:21:25+00:00September 19th, 2018|Financial|

Safe Orthopaedics Announces the Commercial Launch of SteriSpineTMVA, a Balloon for the Vertebral Augmentation

September 18, 2018 ERAGNY-SUR-OISE, France--(BUSINESS WIRE)--Regulatory News: SAFE ORTHOPAEDICS (FR0012452746 – SAFOR) (Paris:SAFOR), a company offering innovative ranges of sterile implants combined with their single-use instruments for back surgery, today announces its worldwide launch of its Kyphoplasty System: the SteriSpineTM VA. The new system adds to an already existing portfolio of sterile & single use devices and

By |2018-09-18T22:31:38+00:00September 18th, 2018|Spine|

NuVasive Announces UK Launch Of MAGEC® X For Early Onset Scoliosis Treatment

SAN DIEGO, Sept. 18, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the United Kingdom (U.K.) launch of MAGEC® X, the newest product generation within the MAGEC pediatric portfolio that addresses early-onset scoliosis (EOS). The development of MAGEC X is distinguished by the inclusion

By |2018-09-18T18:05:05+00:00September 18th, 2018|Spine|

Zavation Medical Products, LLC, a LongueVue Capital Portfolio Company, Completes Investment in Pan Medical U.S. Corp.

JACKSON, Miss., Sept. 18, 2018 /PRNewswire/ -- Zavation Medical Products ("Zavation"), a LongueVue Capital ("LVC") portfolio company, is pleased to announce it has partnered with the management team of Pan Medical U.S. Corp ("PanMed" or the "Company") to acquire the Company. This partnership broadens Zavation's service offering by adding a full suite of minimally invasive products, including the

By |2018-09-18T17:30:52+00:00September 18th, 2018|Financial|

Meditech Spine Receives FDA Clearance for its Cure™ Opel-C Plating System

ATLANTA, Sept. 18, 2018 /PRNewswire/ -- Meditech Spine has received FDA 510(k) clearance to market the Cure™ Opel-C Plate System, an add-on technology to its already cleared CURE™ ACP System and Talos®-C (HA) Interbody Systems. With this approval, Meditech will now offer two additional CURE™ ACP plating options with its Talos® line of cervical interbodies made with the

By |2018-09-18T16:53:29+00:00September 18th, 2018|Regulatory, Spine, Top Stories|

OrthoPediatrics Corp. Announces First PNP | FEMUR Cases Performed in Australia

WARSAW, Ind., Sept. 17, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first surgeries in Australia utilizing the new Pediatric Nailing Platform | FEMUR (“PNP | FEMUR”).  OrthoPediatrics’ sales agent in Australia and New Zealand is Surgical Specialties,

By |2018-09-18T16:21:14+00:00September 18th, 2018|Extremities|

Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018

COLUMBIA, Md., Sept. 17, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announces that GrafixPL PRIME™, a human placental membrane that can be stored at ambient temperatures, launches for sale on October 1, 2018.  The structural matrix, growth factors,

By |2018-09-18T16:03:05+00:00September 18th, 2018|Biologics|

SpineVision® Receives CE Mark for Next-Gen P.L.U.S.® Deformity-Correction Spinal System

ANTONY, France--(BUSINESS WIRE)--SpineVision announced today that it has received CE mark for its next-generation Pivot Link Universal System (P.L.U.S.) spine deformity-correction system. SpineVision will introduce the next-generation P.L.U.S. to spine surgeons at “EuroSpine 2018” (Booth #24C) in Barcelona, Spain (Sept. 19-21), and “NASS 2018” (Booth #1311) in Los Angeles (Sept. 26-29). Deformity of the spine includes any abnormality of the formation, alignment, or shape of the vertebral

By |2018-09-18T15:29:14+00:00September 18th, 2018|Regulatory, Spine, Top Stories|

Conformis Announces Settlement of Patent Dispute with Smith & Nephew

 BILLERICA, Mass., Sept. 17, 2018 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that fit each patient’s unique anatomy, announced today that it has entered into a settlement and license agreement with Smith & Nephew that resolves

By |2018-09-17T23:01:06+00:00September 17th, 2018|Regulatory|